NOVEL SMALL MOLECULE HPK1 INHIBITOR PCC-1 INDUCES STRONG ANTI-TUMOR ACTIVITY

被引：0
|
作者：
Das, Sanjib [1 ]
Mandadi, Sravan [1 ]
Saini, Jagmohan [1 ]
Chaudhari, Sachin [1 ]
Deshpande, Ameya [1 ]
Chinnapattu, Murugan [1 ]
Bajpai, Malini [1 ]
Pangre, Priyanka [1 ]
Potdar, Varada [1 ]
Marathe, Megha [1 ]
Sawant, Pooja [1 ]
Akarte, Atul [1 ]
Misra, Chandrasekhar [2 ]
Das, Subhadip [1 ]
Singh, Anuj [1 ]
Das, Avratanu [1 ]
Lambade, Pandurang [1 ]
Tirumalasetty, Chaitanya [1 ]
Patole, Raju [1 ]
Biswas, Nilanjana [1 ]
Karande, Vikas [1 ]
Shah, Heta [1 ]
Behera, Dayanidhi [1 ]
Gowda, Nagaraj [1 ]
Iyer, Pravin [1 ]
机构：
[1] Glenmark Pharmaceut Ltd, Navi Mumbai, India
[2] Glenmark Pharmaceut, Navi Mumbai, India
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷
关键词：
D O I：
10.1136/jitc-2021-SITC2021.848
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
848
引用
收藏
页码：A889 / A889
页数：1
相关论文
共 50 条
  • [31] Anti-Tumor Activity of Novel Small Molecule Wnt Signaling Inhibitor, CWP232291, In Multiple Myeloma.
    Cha, Joo Young
    Jung, Ji-Eun
    Lee, Kwan-Hoo
    Briaud, Isabelle
    Tenzin, Fnu
    Jung, Hee Kyung
    Pyon, Younghee
    Lee, Donghee
    Chung, Jae Uk
    Lee, Jong Heun
    Oh, Se-Woong
    Jung, Kyung Yun
    Pai, Jin Keon
    Emami, Kathy
    BLOOD, 2010, 116 (21) : 1252 - 1252
  • [32] CCX559 is a potent, orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunity
    Sullivan, Kathleen M. C.
    Vilalta, Marta
    Ertl, Linda S.
    Wang, Yu
    Dunlap, Carolyn
    Ebsworth, Karen
    Zhao, Bin N.
    Li, Shijie
    Zeng, Yibin
    Miao, Zhenhua
    Fan, Pingchen
    Mali, Venkat
    Lange, Christopher
    McMurtrie, Darren
    Yang, Ju
    Lui, Rebecca
    Scamp, Ryan
    Chhina, Vicky
    Kumamoto, Alice
    Yau, Simon
    Dang, Ton
    Easterday, Ashton
    Liu, Shirley
    Miao, Shichang
    Charo, Israel
    Schall, Thomas J.
    Zhang, Penglie
    PLOS ONE, 2023, 18 (06):
  • [33] Anti-tumor activity of novel small molecule inhibitors of mixed protein kinases.
    Narla, RK
    Stein, B
    Ezell, C
    Mortensen, D
    Raymon, HK
    Gamez, J
    Sapienza, J
    Wright, J
    Hughes, K
    Fultz, K
    Delgado, M
    Boluro-Ajayi, M
    Shirley, MA
    Khatsenko, O
    Pai, S
    Clareen, S
    Bhagwat, S
    Sakata, S
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6243S - 6243S
  • [34] Anti-tumor activity of the novel angiogenesis inhibitor anginex
    Dings, RPM
    van der Schaft, DWJ
    Hargittai, B
    Haseman, J
    Griffioen, AW
    Mayo, KH
    CANCER LETTERS, 2003, 194 (01) : 55 - 66
  • [35] An HPK1 inhibitor enhanced the tumour response to anti-PD-1 immunotherapy in non-Hodgkin’s lymphoma
    Lin Yang
    Qiuling Zhao
    Ting Chen
    Wenbin Liu
    Xiuliang Qiu
    Jincan Chen
    Shengqiang Huang
    Ruyi Huang
    Liangliang Dong
    Clinical and Experimental Medicine, 2023, 23 : 3767 - 3780
  • [36] An HPK1 inhibitor enhanced the tumour response to anti-PD-1 immunotherapy in non-Hodgkin's lymphoma
    Yang, Lin
    Zhao, Qiuling
    Liu, Wenbin
    Chen, Ting
    Qiu, Xiuliang
    Chen, Jincan
    Huang, Shengqiang
    Huang, Ruyi
    Dong, Liangliang
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (07) : 3767 - 3780
  • [37] KZR-8834: A novel, small molecule inhibitor of Sec61-dependent protein secretion with anti-tumor activity
    Lowe, Eric
    Anderl, Janet L.
    Fan, Andrea R.
    Jiang, Jing
    Johnson, Henry W.
    Kirk, Christopher J.
    McMinn, Dustin
    Muchamuel, Tony
    Taunton, Jack
    Whang, Jennifer A.
    CANCER RESEARCH, 2019, 79 (13)
  • [38] CCX559 is a potent orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunity.
    Li, Chris
    Vilalta, Marta
    Ertl, Linda S.
    Wang, Yu
    Zeng, Yibin
    Fan, Pingchen
    Lange, Christopher
    McMurtrie, Darren
    Yang, Ju
    Lui, Rebecca
    Scamp, Ryan
    Chhina, Vicky
    Kumamoto, Alice
    Ong, Ryan
    Dang, Ton
    Easterday, Ashton
    Zhao, Niky
    Liu, Shirley
    Singh, Rajinder
    Charo, Israel
    Sullivan, Kathleen
    Schall, Thomas J.
    Zhang, Penglie
    CANCER RESEARCH, 2021, 81 (13)
  • [39] TWT-101: A PHASE 1 STUDY OF THE NOVEL HPK1 INHIBITOR CFI-402411 IN PATIENTS WITH ADVANCED CANCER
    Hamid, Omid
    Bendell, Johanna
    Fu, Siqing
    Papadopoulos, Kyriakos
    Wang, Judy
    Ma, Brigette
    Spreafico, Anna
    Spira, Alexander
    Bray, Mark
    Fletcher, Graham
    Michelson, Glenn
    Roberts-Thomson, Emily
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A519 - A519
  • [40] Broad anti-tumor activity of a novel BET bromodomain inhibitor
    Ma, Yan
    Ben Powell
    Zhang, Jiazhong
    Zhang, Ying
    Carias, Heidi
    Schwertschlag, Ullrich
    Habets, Gaston
    Ibrahim, Prabha
    Spevak, Wayne
    Zhang, Chao
    Bollag, Gideon
    CANCER RESEARCH, 2016, 76
12345